» » University searching to fill vacant dean positions…
» » …After serving as dean for the College of Business Administration
» » eight years, Gail Naughton announced she is leaving the university to
» » as the CEO of Histogen, the biotechnology company she founded in 2007.
» Great find. This is a good sign indeed.
(people, when you post something, please try to post a relevant, summarizing title, not a shïtty title like in this case).
It seems Dr. Naughton is totally commited to her company. I think I have read before, that she is investing much of his personal money into it. Also, the fact that all the workers were woking for free, after the lawsuits, is also moving.
Here is some Naughton’s background that I have just fetched:
Gail K. Naughton
C.R. Bard, Inc.
Murray Hill , NJ
Sector: HEALTHCARE / Medical Instruments & Supplies
Director , Celera Corporation
Alameda , CA
Sector: HEALTHCARE / Diagnostic Substances
54 Years Old
Dr. Gail K. Naughton, Ph.D., Dean, College of Business Administration, San Diego State University since August 2002, and Chairman and Chief Executive Officer of Histogen, Inc. (regenerative medicine) since June 2007, having been Vice Chairman of Advanced Tissue Sciences, Inc. (ATS) (human-based tissue engineering) from March 2002 to October 2002, President from August 2000 to March 2002, President and Chief Operating Officer from 1995 to 2000 and co-founder and director since inception in 1991; age 54. In March 2003, ATS liquidated pursuant to an order of the United States Bankruptcy Court for the Southern District of California, following the filing of a voluntary petition under Chapter 11 in October 2002. Dr. Naughton has been a director of C. R. Bard since July 2004 and is a member of the Governance Committee, Regulatory Compliance Committee, and Science and Technology Committee. She is also a director of Celera Corporation. Dr. Naughton was formerly a director of SYS Technologies, Inc